These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26832202)

  • 1. [Systemic lupus erythematosus with anti-centromere antibodies: An infrequent finding without scleroderma related features].
    Cabrera CM
    Med Clin (Barc); 2016 Oct; 147(7):322-4. PubMed ID: 26832202
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-centromere antibodies in patients with systemic lupus erythematosus.
    Respaldiza N; Wichmann I; Ocaña C; Garcia-Hernandez FJ; Castillo MJ; Magariño MI; Magariño R; Torres A; Sanchez-Roman J; Nuñez-Roldan A
    Scand J Rheumatol; 2006; 35(4):290-4. PubMed ID: 16882593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neonatal lupus syndrome induced by anti-ribonucleoprotein antibodies].
    Victoria-Martínez AM; Esteve-Martínez A; Zaragoza-Ninet V; Febrer-Bosch I
    Med Clin (Barc); 2016 Feb; 146(4):e21-2. PubMed ID: 26520608
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical significance of autoantibody profiles in patients with systemic lupus erythematosus.
    Thompson D; Juby A; Davis P
    Lupus; 1993 Feb; 2(1):15-9. PubMed ID: 8485555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
    Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
    Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and characteristics of anti-single-stranded DNA antibodies in localized scleroderma. Comparison with systemic lupus erythematosus.
    Ruffatti A; Peserico A; Rondinone R; Calligaro A; Del Ross T; Ghirardello A; Germino M; Todesco S
    Arch Dermatol; 1991 Aug; 127(8):1180-3. PubMed ID: 1863075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of antinuclear antibodies for the diagnosis and activity of systemic lupus erythematosus].
    Xie H; Liu Z; Zhu W
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(2):177-8. PubMed ID: 9868068
    [No Abstract]   [Full Text] [Related]  

  • 9. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
    Uchida K; Kondo H; Kashiwazaki S
    Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoantibodies to topoisomerase I in a patient with systemic lupus erythematosus without features of scleroderma.
    Stojanov L; Satoh M; Dooley MA; Kuwana M; Jennette JC; Reeves WH
    Lupus; 1995 Aug; 4(4):314-7. PubMed ID: 8528230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
    Saigal R; Goyal LK; Agrawal A; Mehta A; Mittal P; Yadav RN; Meena PD; Wadhvani D
    J Assoc Physicians India; 2013 Jun; 61(6):372-7. PubMed ID: 24640201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti RNP in systemic lupus erythematosus.
    Melek M; Erdmann MF; Negreiros PH; Skare TL
    Acta Reumatol Port; 2013; 38(2):136-7. PubMed ID: 24141353
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of anticentromere antibody assay].
    Moteki S
    Nihon Rinsho; 1990 Feb; 48 Suppl():580-3. PubMed ID: 2192153
    [No Abstract]   [Full Text] [Related]  

  • 15. [The clinical and diagnostic value of detection of antinuclear factor, antibodies to double-helical DNA and cardiolipin in patients with systemic lupus erythematosus].
    Sozina AV; Ilivanova EP; Shul'man AM; Shul'man MA; Shemerovskaia TG; Lapin SV; Totolian AA
    Klin Lab Diagn; 2008 May; (5):44-7. PubMed ID: 18590168
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic lupus erythematosus. Diagnosis and treatment.
    Pisetsky DS; Gilkeson G; St Clair EW
    Med Clin North Am; 1997 Jan; 81(1):113-28. PubMed ID: 9012757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the specificity of antinuclear antibodies to extractable nuclear antigens in systemic lupus erythematosus patients in Tunisia.
    Gorgi Y; Yalaoui S; Mahfoudh N; Ayed K
    Joint Bone Spine; 2000; 67(4):349-50. PubMed ID: 10963088
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hematologic forms of lupus erythematosus disseminatus with and without antinuclear factors. 25 case reports].
    Blétry O; Mathieu A; Piette JC; Meyer O; Conard J; Wechsler B; Godeau P
    Rev Med Interne; 1983 Mar; 4(1):41-6. PubMed ID: 6603004
    [No Abstract]   [Full Text] [Related]  

  • 19. [The new classification criteria for systemic lupus erythematosus (SLICC)].
    Costedoat-Chalumeau N; Francès C; Pouchot J; Piette JC
    Rev Med Interne; 2014 Aug; 35(8):487-90. PubMed ID: 24467799
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunological analysis of 16 antinuclear antibodies in disseminated lupus erythematosus].
    Boulila Elgaied A; Hintati B; Fakhfakh F; Karray H; Hachicha J; Jarraya A; Ayadi H
    Tunis Med; 1993 Feb; 71(2):91-5. PubMed ID: 8322428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.